{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:06:18Z","timestamp":1790665578776,"version":"4.1.0"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.3201\/eid2602.190533","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T16:34:02Z","timestamp":1578328442000},"page":"332-335","source":"Crossref","is-referenced-by-count":18,"title":["<i>Mycoplasma genitalium<\/i> Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand"],"prefix":"10.3201","volume":"26","author":[{"given":"Anna","family":"Vesty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"McAuliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2602.190533-202001191723-R1","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1128\/JCM.00495-13","article-title":"Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.","volume":"51","author":"Tagg","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2602.190533-202001191723-R2","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/0956462413502008","article-title":"Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.","volume":"24","author":"Couldwell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"key-10.3201\/eid2602.190533-202001191723-R3","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1128\/JCM.01087-17","article-title":"Mycoplasma genitalium macrolide and fluoroquinolone resistance detection and clinical implications in a selected cohort in New Zealand.","volume":"55","author":"Anderson","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2602.190533-202001191723-R4","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1128\/AAC.01956-12","article-title":"Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium.","volume":"57","author":"Yamaguchi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2602.190533-202001191723-R5","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1128\/JCM.00370-17","article-title":"High macrolide resistance in Mycoplasma genitalium strains causing infection in Auckland, New Zealand.","volume":"55","author":"Basu","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2602.190533-202001191723-R6","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1093\/jac\/dku164","article-title":"Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.","volume":"69","author":"Kikuchi","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2602.190533-202001191723-R7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1128\/JCM.42.2.683-692.2004","article-title":"Use of TaqMan 5\u2032 nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic.","volume":"42","author":"Jensen","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2602.190533-202001191723-R8","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/jac\/48.5.742","article-title":"Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment.","volume":"48","author":"Deguchi","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2602.190533-202001191723-R9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3201\/eid2305.161745","article-title":"Increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium.","volume":"23","author":"Murray","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2602.190533-202001191723-R10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ijantimicag.2010.05.011","article-title":"Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in parC associated with fluoroquinolone resistance.","volume":"36","author":"Shimada","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid2602.190533-202001191723-R11","doi-asserted-by":"publisher","first-page":"e0198355","DOI":"10.1371\/journal.pone.0198355","article-title":"Mutations in parC and gyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.","volume":"13","author":"Hamasuna","year":"2018","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2602.190533-202001191723-R12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.diagmicrobio.2016.07.005","article-title":"Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany.","volume":"86","author":"Dumke","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.3201\/eid2602.190533-202001191723-R13","doi-asserted-by":"crossref","unstructured":"Golden MR, Workowski KA, Bolan G. Developing a Public Health Response to Mycoplasma genitalium. J Infect Dis. 2017;216(suppl_2):S420\u20136.","DOI":"10.1093\/infdis\/jix200"},{"key":"key-10.3201\/eid2602.190533-202001191723-R14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3201\/eid2402.170902","article-title":"Use of pristinamycin for macrolide-resistant Mycoplasma genitalium infection.","volume":"24","author":"Read","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2602.190533-202001191723-R15","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1128\/AAC.44.10.2719-2727.2000","article-title":"Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin.","volume":"44","author":"B\u00e9b\u00e9ar","year":"2000","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/26\/2\/19-0533_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:32:24Z","timestamp":1732987944000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/26\/2\/19-0533_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2602.190533","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}